Skip to main content

RHUMBLINE ADVISERS

Position in OCUL — Ocular Therapeutix, Inc

CIK 1115418 BOSTON, MA

Position in OCUL

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$2,657,704
+$700,279 QoQ
Shares Held
270,642
+17.1% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#69
of 257 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 25% Shared 0% None 75%

Common Shares in OCUL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,404,298,250 across 329 Biotechnology names. OCUL ranks #83 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in OCUL

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,657,704 270,642
2026-03-31 $1,957,425 231,101
2025-12-31 $2,929,636 241,321
2025-09-30 $2,571,893 220,008
2025-06-30 $2,093,085 225,548
2025-03-31 $1,635,432 223,115
2024-12-31 $1,824,152 213,601
2024-09-30 $1,808,895 207,919
2024-06-30 $1,445,298 211,301
2024-03-31 $1,382,799 151,956
2023-12-31 $508,283 113,965
2023-09-30 $408,250 130,016
2023-06-30 $630,670 122,223
2023-03-31 $568,290 107,835
2022-12-31 $284,773 101,343
2022-09-30 $412,227 99,332
2022-06-30 $363,789 90,495
2022-03-31 $438,901 88,667
2021-12-31 $607,212 87,118
2021-09-30 $889,620 88,962
2021-06-30 $1,206,959 85,117
2021-03-31 $1,370,661 83,526
2020-12-31 $1,774,300 85,715
2020-09-30 $538,331 70,740
2020-06-30 $636,370 76,395
2020-03-31 $283,407 57,254